Till Dominik Best

7PUBLICATIONS
54CO-AUTHORS
Infant and child healthMedical biotechnology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Bioinformatic methods developmentPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 15, 2026
Post-Exposure Prophylaxis with a monoclonal antibody cocktail Following Bundibugyo Ebolavirus Exposure in Adults and Children.

|Sep 15, 2026
A case of Bundibugyo virus disease treated with monoclonal antibodies and remdesivir.

|May 06, 2025
Artificial intelligence-based muscle analysis risk assessment of treatment-related toxicity in metastatic colorectal cancer.

Matthew Lei, Ryan D Nipp, Erica Tavares

|Feb 11, 2022
A Fully Automated Deep Learning Pipeline for Multi-Vertebral Level Quantification and Characterization of Muscle and Adipose Tissue on Chest CT Scans.

Christopher P Bridge, Till D Best, Maria M Wrobel

|Apr 05, 2021
Muscle Loss Is Associated with Overall Survival in Patients with Metastatic Colorectal Cancer Independent of Tumor Mutational Status and Weight Loss.

Till Dominik Best, Eric J Roeland, Nora K Horick

|Jan 29, 2021
Associations of Skeletal Muscle With Symptom Burden and Clinical Outcomes in Hospitalized Patients With Advanced Cancer.

Emily van Seventer, J Peter Marquardt, Amelie S Troschel

Pageof 2

Frequent Collaborators

3 joint publications

Christopher P Bridge

3 joint publications

Florian J Fintelmann

2 joint publications

Amelie S Troschel

2 joint publications

William A Fischer